Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio Published 2023-02-22 Download video MP4 360p Download video MP4 720p Recommendations 1:02:00 Moderna at SXSW 2022 with President Stephen Hoge and FORTUNE Editor-in-Chief Alyson Shontell 1:01:16 Peter Thiel: The Stagnation of Science and the AI Revolution 10:06 Moderna will apply ‘same intensity’ for cancer vaccine as it did for COVID, CEO says 07:28 Roaring Kitty's return to social media sparks meme stock rally 24:02 Google CEO Sundar Pichai and the Future of AI | The Circuit 05:45 What April's CPI data could mean for Fed rate cuts, plus opportunities for investors 14:16 'I finally got COVID': CBC host | About That 15:40 CEO Chat with Stéphane Bancel @ Flagship Studio 06:45 Moderna stock upgraded to outperform by Oppenheimer & Co 12:42 Google DeepMind CEO on Drug Discovery, Hype, Isomorphic 09:41 Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial 04:24 We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter 08:08 Moderna CEO Stephane Bancel on Q4 results: There is so much more to Moderna than Covid 24:44 Therapist Answers Most Googled Questions About ADHD 05:43 The power of mRNA technology and its potential to impact global public health 15:47 Vinod Khosla’s View on the Global Race in AI 05:07 Inflation: 2 things the Fed needs to see to cut rates 09:39 Google's fate hinges on this man: Demis Hassabis 06:42 GameStop stock surges: YF examines GME and other meme stocks 07:20 Moderna CEO on combo Covid, flu vaccine moving to next trial phase Similar videos 00:31 Our mRNA Plaform 08:44 COVID-19 ‘is not leaving the planet,’ Moderna CEO says 09:09 Moderna (MRNA) CFO On Covid Vaccine Demand & Earnings 06:46 Moderna CEO discusses earnings and how the company aims to break even by 2026 03:40 Falling COVID-19 vaccine sales weigh on Moderna’s Q4 earnings results 02:05 Moderna and Pfizer stocks rise amid new Covid variants 04:49 Moderna's mRNA RSV vaccine propels stock gains 15:12 Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advances 01:26 Welcome to the mRNAge 03:10 Moderna stock rises on positive results in flu vaccine trial 2:41:05 Moderna CEO appears before Senate Hearing on COVID-19 vaccine pricing 3:08:50 Moderna Annual R&D Day 2022 01:05 Episode 5: mRNA Research Explained, with Cleo Abram 01:10 Episode 4: mRNA Research Explained, with Cleo Abram 02:36 Moderna and Merck’s cancer vaccine trial shows promising initial results 00:20 Moderna entered the S&P 500 on July 21, 2021 06:12 The science behind Moderna’s vaccine development More results